Critical Care Cardiology Trials Network
@ccctnetwork
CCCTN is an investigator-initiated network founded in 2017 to study the epidemiology of cardiac critical illness and undertake pragmatic CICU-based trials.
ID: 1677325821097156608
07-07-2023 14:37:18
39 Tweet
175 Followers
51 Following
⭐️Proud of our chief fellow and future interventionalist Tanya Sharma for her stellar presentation at #ESCCongress2024 on young patients in the CICU! 🏥 Our fellows have access to premier research databases such as Critical Care Cardiology Trials Network enabling them to collaborate with national leaders 🙌🏻
Recognition of preshock or early CS states is important to facilitate early identification, to guide appropriate triage and to enable prompt interventions aimed at delaying or preventing the onset of overt CS. bit.ly/3zeRsQn #JACCHF Sid M. Patel TIMI Study Group
🔥🔥 ☠️ for phenotypes along preshock -> CS continuum 👉 jacc.org/doi/full/10.10… JACC Journals #JACCHF Critical Care Cardiology Trials Network 🎯 Hypoperfusion +/- hypotension -> ⬆️☠️ 🎯 normotensive CS -> distinct CS phenotype 🎯 Identify pre-& early shock to improve #CardiogenicShock outcomes
Phenomenal talk by #DrDavidMorrow on impact of Critical Care Cardiology Trials Network on #waronshock #TCT24 TCT Conference Cardiovascular Research Foundation Jason N. Katz Sean van Diepen David Berg Erin Bohula Sid M. Patel Ajar Kochar TIMI Study Group
How should we apply #DanGer #Shock results in U.S.? #DrDavidMorrow shares insights #Patient selection 🔑 Critical Care Cardiology Trials Network TIMI Study Group Jason N. Katz Sean van Diepen David Berg Erin Bohula Ankeet S. Bhatt, MD, MBA TCT Conference #TCT24
Dr. Robert Ariss presents his oral abstract on Trends In Temperature Control After Cardiac Arrest In Cardiac Intensive Care Units in this Critical Care Cardiology Trials Network analysis, tomorrow at 8am in S101A Robert Ariss @ddbergmd #AHA24
See Jason N. Katz present his oral abstract on recidivism in the #CICU in this Critical Care Cardiology Trials Network analysis, 24 hours from now in S101A #AHA24
In this Critical Care Cardiology Trials Network analysis, David Hamilton reviews variation in vasoactive treatments for cardiogenic shock, tomorrow at 11:50 in Zone 4, Moderated Digital Poster 17 #AHA24
Don't miss Curt Ginder's presentation on Association Between Pressure-adjusted Heart Rate and Mortality in Cardiogenic Shock, in 24 hours in Zone 4, Moderated Digital Poster 17 Critical Care Cardiology Trials Network David Berg #AHA24
Dr. Gurleen Kaur, MD will analyze characterization of isolated right ventricular congestion in cardiogenic shock, tomorrow at 1:40pm in Zone 4‚ Moderated Digital Poster 17 @ebohula Critical Care Cardiology Trials Network #AHA24
Kicking off an “arresting” session at #AHA24 - Robert Ariss from Brigham and Women's Hospital TIMI Study Group discussing evolutionary trends in TTM following cardiac arrest 3CPR Council Critical Care Cardiology Trials Network
In contemporary CICUs, target temperatures for comatose cardiac arrest patients have shifted towards normothermia since publication of the TTM2 Trial. Robert Ariss David Berg Critical Care Cardiology Trials Network #AHA24
New data from the Critical Care Cardiology Trials Network & @UmichCVC shows significant variation in vasoactive medication use in the treatment of cardiogenic shock across different CICU centers. 23% of variation was explained by local institutional practice alone. @davyhamilton1 @sidpatelMD #AHA24
In this Critical Care Cardiology Trials Network analysis, pts w/CS & isolated RV congestion had worse presenting severity of shock, ⬆️use of CICU resources, ⬆️CICU mortality. These findings support prognostic utility of recognizing pts with an isolated RV congestive profile Gurleen Kaur, MD @ebohula #AHA24
In an analysis of pts w/cardiogenic shock from the Critical Care Cardiology Trials Network registry, PAHR (HR*RAP/MAP) was strongly associated with in-hospital mortality and outperformed traditional hemodynamic metrics David Berg Curt Ginder #AHA24
